News
Bio-tech firm develops 3D printed replacement cornea for human eyes
After successfully transplanting the first 3D-printed cornea in an animal, North Carolina company Precise Bio has recently announced the launch of a dedicated business for creating marketable, 3D-printed products for human eyes. Founded by scientists from the Wake Forest Institute of Regenerative Medicine, this company is developing bio-fabrication printers that can restore cells, tissues, and organs. Their proprietary technology, a 4D bio-printing platform, is said to resolve existing limitations presented by other bioprinters to enable more complex tissues to be engineered for transplants and treatments. By focusing on developing marketable products for the eye, the company aims to achieve rapid advancement in its field and move to overhaul the whole organ transplant system.
A cornea transplant with sutures still visible. | Credit: National Institutes for Health, National Eye Institute
When a cornea is damaged by disease or injury, a replacement is often needed to restore vision. Transplant surgery using donated corneas is an available solution, however, it relies on a deceased donor. While the waiting list in the United States is nearly non-existent, other countries require longer wait times, some over a year, before one is available. The Eye Bank Association of America estimates that around 10 million people suffer from corneal blindness that could potentially be restored via transplant surgery. An artificially manufactured cornea would overcome supply limitations while also contributing to the knowledge base to develop more complex organs such as hearts and livers.
The cornea is the transparent layer covering the front part of the eye that, along with the lens, accounts for about two-thirds of the eye’s optical power. It does not contain blood vessels, making it a prime candidate for bioprinting, the field of 3D printing involving biological materials. Bioprinters differ from traditional 3D printers in ways that might not be surprising given their name. Instead of heated filament applied in layers on a plate to build an object, layers of cells and biocompatible materials are printed to form tissue. Along with a lack of blood vessels, the layered structure of the cornea also makes it well suited for bioprinting.
Precise Bio refers to its printing technique used for the corneas and other biomaterials as “4D” over the usual “3D” label due to the curing stage for the printed cells. The fourth dimension referred to is time needed, 10-14 days specifically, for the bio-printed cells and fibers to connect themselves together for biological operation in a bioreactor that keeps them warm for the duration. Aryeh Batt, Precise Bio’s CEO, summarized this step in an interview with IEEE Spectrum: “Essentially, the biology does the work, but you have to put them in the correct environment to make it happen.”
Initial animal safety studies for the corneal transplant have already been completed, and now the company must clear some additional hurdles to begin human testing. One of the major proofs for Precise Bio will be the demonstration of normal behavior of the bio-printed products. For example, during production using the 3D/4D printer, the printed cells grow rapidly into the form needed in a way that does not occur in a normal eye. The company will have to demonstrate in clinical studies how this process is controlled and stopped before transplant.
The field of 3D bioprinting is a research area receiving a significant amount of attention due to its potential for developments in tissue engineering, drug delivery, and cancer studies. In fact, hundreds of scientific articles were published on the topic this year alone. As with most new technology, however, the challenge of moving a development out of the laboratory and into the consumer marketplace is significant, but Precise Bio hopes to meet it head on with its new dedicated business.
For more on bioprinting, watch the below Tedx Talk by Dr. Sam Wadsworth of Aspect biosystems Ltd.
Tesla’s Cybercab has taken a significant step toward production with new technical details emerging from 2026 EPA certification documents.
The filings, which include a Certificate of Conformity issued in late May, provide the most comprehensive public look yet at the purpose-built autonomous vehicle designed for high-volume, low-cost ride-hailing operations.
At its core, the Cybercab is a front-wheel-drive electric vehicle powered by a single 163 kW (219 horsepower) AC permanent magnet motor. Despite its modest output, prioritizing efficiency and cost over neck-snapping acceleration, the vehicle boasts a strong power-to-weight ratio thanks to its lightweight curb weight of 3,113 pounds and a GVWR of 3,730 pounds.
It operates on a 326-volt electrical architecture with a compact ~48 kWh lithium-ion battery pack. The standout revelation is the vehicle’s exceptional efficiency, which Tesla has routinely flexed in the past.
EPA lab tests list an equivalent all-electric range of 418 miles combined and 375 miles on the highway. Tesla has previously targeted around 300 miles of real-world range, and analysts expect the final EPA-rated figure to land near 280-300 miles after adjustment factors.
At a certified 165 Wh/mi in earlier testing, the Cybercab is reportedly the most efficient EV ever produced, significantly outperforming vehicles like the Lucid Air Pure.
New information about @Tesla‘s Cybercab has been revealed in public EPA documents.
• Front-wheel drive
• Battery capacity: ~48 kWh
• 219 horsepower
• Curb weight: 3,113 lbs
• GVWR: 3,730 lbs
• Motor power: 163kW
• Voltage: 326vEquivalent All Electric Range is listed at… pic.twitter.com/D4gkJJTj25
— Sawyer Merritt (@SawyerMerritt) June 15, 2026
This efficiency stems from deliberate design choices tailored for robotaxi duty. The two-seater features a highly aerodynamic shape, minimal weight, which is aided by structural battery integration of what are likely 4680 cells, and no steering wheel or pedals in its fully autonomous configuration.
For ride-hailing fleets, where average trips are short, and can be just five or ten miles, the smaller battery enables faster charging cycles, lower material costs, and reduced vehicle price, a key to Tesla’s goal of a ~$30,000 production cost.
Implications for Autonomous Mobility
These specs underscore Tesla’s strategy: maximize utilization and minimize operating expenses. A ~48 kWh pack could support dozens of short rides per charge, with energy costs potentially dropping below 20 cents per mile at scale. Front-wheel drive simplifies manufacturing and maintenance compared to dual-motor AWD setups in passenger Teslas.
The 219 hp motor provides ample performance for urban and highway speeds without excess, addressing questions about why such power is needed in a “slow” autonomous vehicle. Quick merges and hill climbing still matter for safety and passenger comfort.
Production has already begun at Giga Texas, with EPA certification clearing the path for U.S. deployment. While unsupervised Full Self-Driving remains the critical hurdle, these details paint a compelling picture of a vehicle engineered from the ground up for the robotaxi future: affordable to build, cheap to run, and capable of delivering strong range on a fraction of the battery capacity found in today’s EVs.
As Tesla ramps toward volume output, the Cybercab could reshape urban transportation economics.
Tesla Cybercab, the all-electric ride-hailing-geared vehicle void of a steering wheel and pedals, has achieved a significant regulatory milestone. The vehicle has officially secured an EPA Certificate of Conformity for the 2026 Cybercab, classifying it as a battery electric Zero Emission Vehicle (ZEV).
This certification confirms full compliance with federal Clean Air Act emission standards, paving the way for legal sales and operation across the United States.
A Certificate of Conformity (CoC) is a critical document issued by the U.S. Environmental Protection Agency (EPA) to vehicle manufacturers. It certifies that a specific class of vehicles meets all applicable federal emission requirements for the model year.
We have reported on several of them in the past, and it’s a good sign that a vehicle is close to being available to the public.
Every vehicle sold in the U.S. must carry this approval, which covers exhaust emissions, evaporative emissions, and refueling standards. For battery electric vehicles like the Cybercab, it verifies zero tailpipe emissions and compliance with stringent testing protocols. The certificate, issued and effective May 26, 2026, was part of the EPA’s recent bi-weekly upload, detailing the Cybercab’s evaporative/refueling family and exhaust compliance.
It also revealed some other very important information, as the Cybercab’s “Charge Depleting Range” was rated at just over 418 miles. This was for city driving, while the highway range depletion test revealed just over 375 miles of range:
Highway miles for Charge Depleting Range was just over 375 miles
— TESLARATI (@Teslarati) June 15, 2026
This EPA approval is a foundational step for Tesla’s autonomous ambitions. While emission certification is standard for any new EV, it signals that the Cybercab is progressing through the full federal compliance process.
Tesla has already equipped prototypes with federal compliance stickers affirming adherence to safety, bumper, and theft-prevention standards via self-certification under FMVSS rules. This bypasses the traditional 2,500-vehicle exemption cap that previously constrained low-volume autonomous testing.
Production of the Cybercab ramped up at Giga Texas starting in early 2026, with volume targets aiming for hundreds of units per week and long-term ambitions of millions annually. The two-seater, steer-by-wire vehicle, lacking a steering wheel and pedals, features a sleek, minimalist design optimized for Robotaxi service.
Priced under $30,000 at unveiling, it promises operating costs as low as $0.20–$0.40 per mile once scaled. Tesla has routinely flexed it as one of the most efficient vehicles of all time.
Regulatory progress extends beyond the EPA. The NHTSA has streamlined approvals for control-free vehicles, benefiting the Cybercab. Tesla operates supervised and unsupervised Robotaxi services in Texas cities like Austin, Dallas, and Houston using its fleet. California recently updated rules for driverless operations, including enforcement mechanisms for violations. Additional state-by-state approvals will be needed for nationwide rollout.
This EPA green light reduces a key barrier, building confidence among regulators, partners, and investors.
It underscores Tesla’s strategy of designing the Cybercab from the ground up for full compliance rather than retrofitting existing platforms. Challenges remain in scaling unsupervised autonomy, mapping approvals, and public acceptance, but the certification marks tangible momentum toward transforming urban mobility.
With prototypes already testing on public roads and production accelerating, the Cybercab edges closer to redefining transportation. Tesla’s integrated approach—combining hardware simplicity, software prowess, and regulatory diligence—positions it uniquely in the robotaxi race.
SpaceX executed its first Falcon 9 launch since going public on June 15, a routine yet symbolically powerful Starlink mission from Vandenberg Space Force Base in California.
Liftoff of the Falcon 9 booster B1093, on its 14th flight, occurred at approximately 8:34 a.m. PDT from Space Launch Complex 4E (SLC-4E), deploying 24 Starlink V2 Mini Optimized satellites into low-Earth orbit.
The first stage successfully landed on the droneship “Of Course I Still Love You” in the Pacific Ocean, underscoring the company’s unmatched reusability track record.
Watch Falcon 9 launch 24 @Starlink satellites to orbit from California https://t.co/meDwb05qOE
— SpaceX (@SpaceX) June 15, 2026
This mission comes just three days after SpaceX’s historic IPO on June 12, which shattered records as the largest ever. The company raised $75 billion by pricing shares at $135, with trading under ticker SPCX on Nasdaq opening at $150 and closing at $160.95—a 19 percent gain—valuing SpaceX at over $2.1 trillion.
The launch highlights the seamless transition from private innovator to public powerhouse. SpaceX, founded in 2002, has revolutionized access to space with over 650 Falcon 9 flights and a massive Starlink constellation now serving millions globally.
As a public company, it faces new pressures: quarterly earnings, shareholder scrutiny, and expectations to accelerate Starship development for Mars ambitions and deeper NASA partnerships. Yet the market response signals strong confidence in its dominance, as launch costs are slashed by 95 percent, rapid satellite deployment, and a backlog of government and commercial contracts.
SpaceX maintains bold advertising push for Starlink, contrasting Tesla’s minimalistic approach
Analysts view today’s flight as business as usual, but it carries extra weight. With shares volatile in early trading days, successful operations reassure investors that core capabilities remain unaffected by public status.
SpaceX now operates under heightened transparency, potentially unlocking capital for ambitious goals like Starship orbital tests and global broadband expansion.
Challenges loom, including regulatory hurdles for megaconstellations, competition in reusable rockets, and orbital debris concerns. Nevertheless, this morning’s flawless execution reinforces SpaceX’s trajectory.
As Musk often notes, the company’s mission—to make humanity multiplanetary—now aligns with Wall Street’s growth demands. The stars, it seems, are aligning for both.
Tesla Cybercab specs revealed: range, curb weight, range ratings, and more
Tesla Cybercab snags huge regulatory green light that readies it for public roads
